#1 Clinical Trials Search in Europe

Glibenclamide

This article examines the use of glibenclamide, a medication traditionally used to treat type 2 diabetes, in various clinical trials. We’ll explore its applications not only in diabetes management but also in treating conditions like traumatic brain injury and stroke. The trials investigate glibenclamide’s effects on blood sugar control, endothelial function, and its potential to reduce brain edema in neurological conditions.

Table of Contents

What is Glibenclamide?

Glibenclamide, also known by its brand names Glibesyn, Daonil, or Glinbentek, is an oral medication primarily used to treat type 2 diabetes[1]. It belongs to a class of drugs called sulfonylureas, which are widely used in the management of diabetes[2]. Glibenclamide has been a cornerstone in diabetes treatment for many years and is known for its effectiveness in controlling blood sugar levels.

Conditions Treated by Glibenclamide

While glibenclamide is primarily used for treating type 2 diabetes, recent research has explored its potential in treating other conditions:

  • Type 2 Diabetes Mellitus: This is the main condition for which glibenclamide is prescribed. It helps control blood sugar levels in patients with this form of diabetes[3].
  • Neonatal Diabetes: This is a rare form of diabetes that occurs in newborns. Studies have shown that glibenclamide can be effective in treating certain types of neonatal diabetes caused by genetic mutations[2][4].
  • Brain Edema in Traumatic Brain Injury: Researchers are investigating whether glibenclamide can help reduce brain swelling (edema) in patients with severe head injuries[5].
  • Stroke: Some studies are exploring the potential of glibenclamide in improving outcomes for patients who have had a stroke[6].

How Glibenclamide Works

Glibenclamide works by stimulating the release of insulin from the pancreas. Here’s a simplified explanation of its mechanism:

  1. It binds to specific receptors (called SUR1) on the pancreatic beta cells.
  2. This binding causes potassium channels in the cell membrane to close.
  3. The closure of these channels leads to an increase in calcium within the cell.
  4. The rise in calcium triggers the release of insulin from storage granules in the cell.
  5. The released insulin then helps to lower blood sugar levels by promoting the uptake of glucose by cells in the body[2].

In the case of neonatal diabetes caused by certain genetic mutations, glibenclamide can help overcome the defect in insulin release, allowing for better blood sugar control[4].

Dosage and Administration

The dosage of glibenclamide can vary depending on the condition being treated and the individual patient’s needs. Here are some general guidelines:

  • For type 2 diabetes in adults, the typical dose ranges from 2.5 mg to 20 mg per day, often divided into multiple doses[3].
  • For neonatal diabetes, the dosage is much lower and is carefully adjusted based on the child’s weight and response to the medication. It’s often given as an oral solution for easier administration to infants[4].
  • In research settings for conditions like brain injury or stroke, lower doses (such as 1.25 mg every 8 hours) are being studied[5][6].

It’s crucial to take glibenclamide exactly as prescribed by your doctor. The medication is usually taken orally, with meals to reduce the risk of low blood sugar.

Potential Side Effects

Like all medications, glibenclamide can cause side effects. The most common and important ones to be aware of include:

  • Hypoglycemia (low blood sugar): This is the most significant risk. Symptoms can include sweating, shakiness, confusion, and in severe cases, loss of consciousness[7].
  • Weight gain: Some patients may experience weight gain while taking glibenclamide.
  • Gastrointestinal issues: Nausea, vomiting, or diarrhea can occur in some patients.
  • Allergic reactions: Although rare, some people may develop an allergic reaction to the medication.

It’s important to discuss any side effects with your healthcare provider. They can adjust your dose or consider alternative treatments if necessary.

Ongoing Research and Potential New Uses

Researchers are continually studying glibenclamide to understand its full potential. Some areas of ongoing research include:

  • Brain Injury Treatment: Studies are investigating whether glibenclamide can help reduce brain swelling and improve outcomes in patients with severe traumatic brain injuries[5].
  • Stroke Management: Research is exploring if glibenclamide can help improve recovery in patients who have had a stroke, particularly when used alongside standard stroke treatments[6].
  • Improved Formulations: Work is being done to develop new forms of glibenclamide that may be easier to administer, especially for children with neonatal diabetes[4].

These research efforts may lead to new uses for glibenclamide in the future, potentially benefiting patients with a wider range of conditions.

Aspect Details
Primary Use Treatment of type 2 diabetes
Mechanism of Action Stimulates insulin release from pancreatic beta cells
New Applications Potential treatment for brain edema in TBI and stroke
Dosage in Trials Varies; ranges from 0.3mg to 20mg daily
Side Effects Hypoglycemia is most common
Comparisons Being compared to newer diabetes drugs like vildagliptin
Special Populations Being studied in children with neonatal diabetes

FAQ

  • What is glibenclamide primarily used for? Glibenclamide is primarily used to treat type 2 diabetes. It belongs to a class of medications called sulfonylureas, which help lower blood sugar levels by stimulating insulin release from the pancreas.
  • How is glibenclamide being studied in brain injuries? Researchers are investigating glibenclamide's potential to reduce brain edema (swelling) in conditions like traumatic brain injury and stroke. Some trials are exploring whether it can improve outcomes when combined with standard treatments for these conditions.
  • What are some potential side effects of glibenclamide? The most common side effect of glibenclamide is hypoglycemia (low blood sugar). Other potential side effects can include nausea, skin reactions, and rarely, liver or blood disorders. It's important to monitor blood sugar levels closely when taking this medication.
  • How does glibenclamide compare to other diabetes medications in clinical trials? Some trials are comparing glibenclamide to newer diabetes medications like vildagliptin, particularly in terms of their effects on endothelial function and cardiovascular risk factors in patients with type 2 diabetes and hypertension.
  • Can glibenclamide be used in children with diabetes? There are clinical trials investigating the use of glibenclamide in children with neonatal diabetes mellitus, particularly those with specific genetic mutations. These studies aim to determine if glibenclamide can replace insulin injections in these patients.

Ongoing Clinical Trials on Glibenclamide

  • Study of Drug Combination with Amodiaquine and Potassium Canrenoate Plus Exenatide or Glibenclamide for Patients with Acute Ischemic Stroke

    Not yet recruiting

    1 1
    Investigated drugs:
    Greece

  • Evaluation of Long-Term Efficacy and Safety of Tirzepatide Versus Intensified Conventional Care in Early Treatment of Type 2 Diabetes in Adults

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Czechia Germany Italy Romania Slovakia

  • Study on Oral Glibenclamide for Managing High Blood Sugar in Premature Infants Weighing Less Than 1500g

    Not recruiting

    1 1 1
    Investigated drugs:
    France

Glossary

  • Glibenclamide: A medication used to treat type 2 diabetes. It belongs to the sulfonylurea class of drugs and works by stimulating insulin release from the pancreas to lower blood sugar levels.
  • Endothelial function: The ability of the inner lining of blood vessels (endothelium) to regulate vascular tone and blood flow. It's an important marker of cardiovascular health.
  • Hypoglycemia: A condition where blood sugar levels drop below normal, which can cause symptoms like shakiness, confusion, and in severe cases, loss of consciousness.
  • Traumatic brain injury (TBI): A disruption in normal brain function caused by a blow or jolt to the head. It can result in various physical, cognitive, and emotional symptoms.
  • Neonatal diabetes mellitus: A rare form of diabetes that occurs in the first 6 months of life. It can be caused by genetic mutations and may require lifelong treatment.
  • Bioequivalence: The absence of a significant difference in the rate and extent at which the active ingredient in pharmaceutical equivalents becomes available at the site of drug action when administered at the same dose under similar conditions.
  • Reactive hyperemia index (RHI): A measure of endothelial function that assesses how well blood vessels dilate in response to increased blood flow.
  • Subarachnoid hemorrhage: A type of stroke caused by bleeding in the space between the brain and the surrounding membrane. It can lead to severe headaches and brain damage.

References

  1. https://clinicaltrials.gov/study/NCT03855306
  2. https://clinicaltrials.gov/study/NCT00610038
  3. https://clinicaltrials.gov/study/NCT02145611
  4. https://clinicaltrials.gov/study/NCT02375828
  5. https://clinicaltrials.gov/study/NCT05148403
  6. https://clinicaltrials.gov/study/NCT03284463
  7. https://clinicaltrials.gov/study/NCT00734669